Exercise News and Research

Latest Exercise News and Research

Exercise helps retain greater bone density: Researchers

The stage for osteoporosis is set well before menopause-but exercise can help rewrite the script, according to Medical College of Georgia researchers.

26 Apr 2010

Novartis exercises current right to purchase 55,223 unregistered shares of Alnylam's common stock

Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that Novartis has elected to fully exercise its current right to purchase 55,223 unregistered shares of Alnylam's common stock in accordance with the terms of the Investor Rights Agreement between Alnylam and Novartis, dated September 6, 2005.

26 Apr 2010

BioSante signs Option Agreement to obtain non-exclusive worldwide license for 2A/Furin technology

BioSante Pharmaceuticals, Inc. today announced that it has entered into an Option Agreement with an undisclosed large multi-national pharmaceutical company to obtain a non-exclusive worldwide license for the use of BioSante's 2A/Furin technology in the expression of antibodies.

26 Apr 2010

Covidien introduces PENNSAID to the U.S. market

Covidien, a leading global provider of healthcare products, has introduced PENNSAID (diclofenac sodium topical solution) 1.5% w/w to the U.S. market. PENNSAID is the only FDA-approved topical non-steroidal anti-inflammatory drug in a vehicle solution containing dimethyl sulfoxide, a known penetrating agent. It is indicated for treatment of the signs and symptoms of osteoarthritis of the knee(s).

26 Apr 2010

Spring fever not an official medical condition

In the season of ducklings, blooming dogwoods and open-toed sandals, some people are struck with a mysterious malady - spring fever.

24 Apr 2010

Overweight adolescent children tend to follow weight-control strategies of their parents: Study

When parents maintain a healthy body image and weight-control strategies, overweight adolescent children tend to follow their example, a new study reveals.

24 Apr 2010

NPAF urges Colorado Governor to exercise line item veto of $17.9M reduction in 2011 Medicaid program

The National Patient Advocate Foundation, a national, non-profit organization dedicated to the mission of creating avenues of improved patient access to health care through public policy reform at the state and federal levels, delivered a letter to Colorado Governor Bill Ritter, urging him to exercise a line item veto of a $17.9 million reduction in Medicaid funding passed recently by the Colorado legislature as part of the fiscal year 2011 budget.

24 Apr 2010

Victoza produces greater reductions in A1C, FPG and body weight than Januvia: Study

Yesterday, The Lancet published online the results of the first study comparing the once-daily human GLP-1 analog, Victoza (liraglutide [rDNA] injection) with a DPP-4 inhibitor, Januvia. The 26-week trial showed that Victoza produced significantly greater reductions in A1C, fasting plasma glucose, and body weight than Januvia, with similar or better overall treatment satisfaction.

24 Apr 2010

Broadspire, Medcor partner to provide direct immediate post-injury treatment for employees

Broadspire, a Crawford Company and leading third party administrator of workers compensation claims, liability claims and medical management services, and Medcor, a leading injury triage provider, are partnering to implement services to more effectively direct immediate post-injury treatment for employees.

24 Apr 2010

Arcadia Capital Advisors MD commences all-cash tender offer for CPEX Pharmaceuticals

Arcadia Capital Advisors Managing Director Richard Rofé announced today that he has commenced a $16.00 per share all-cash tender offer for CPEX Pharmaceuticals, Inc. through RSR Acquisition Co., a wholly-owned subsidiary of Shelter Bay Holdings, LLC.

23 Apr 2010

Cipher Pharmaceuticals' first-quarter total revenue up 52%

Cipher Pharmaceuticals Inc. today announced its financial and operational results for the three months ended March 31, 2010.

23 Apr 2010

More tips to protect lungs on elevated-ozone days

It's a harmless-looking pale blue gas, a relative of the oxygen molecule that sustains life. In the upper atmosphere, a layer of it protects us from the sun's harmful rays.

23 Apr 2010

Micromedex clinical decision support and CareNotes content to be integrated within M2 HCIS

Micromedex clinical decision support and CareNotes® patient education content from Thomson Reuters will be integrated within the M2 Health Care Information System (HCIS).

23 Apr 2010

Medical Properties Trust closes underwritten public offering of common stock

Medical Properties Trust, Inc. announced today that it closed the sale of its previously announced underwritten public offering of shares of common stock, which included 26 million shares of common stock issued on April 20, 2010 and 3.9 million shares of common stock issued on April 22, 2010 pursuant to the exercise in full of the underwriters' over-allotment option.

23 Apr 2010

Nile Therapeutics prices underwritten public offering of common stock

Nile Therapeutics, Inc., a company focused on the development of novel therapeutics for heart failure patients, announced the pricing of its previously announced underwritten public offering of 6,500,000 units of its securities at a public offering price of $0.70 per unit. Each unit consists of one share of Nile common stock and 0.30 warrants to purchase common stock.

23 Apr 2010

Physical exercise and computer use may help protect against mild cognitive impairment: Mayo Clinic

A new Mayo Clinic study found that physical exercise and computer use may help protect against mild cognitive impairment, a disorder of the brain that affects nerve cells involved in thinking abilities.

23 Apr 2010

Amylin, Eli Lilly and Alkermes reply to FDA complete response letter for BYDUREON NDA

Amylin Pharmaceuticals, Inc., Eli Lilly and Company and Alkermes, Inc. today announced that the companies have submitted their reply to a complete response letter issued last month by the U.S. Food and Drug Administration (FDA) after review of the New Drug Application (NDA) submission for BYDUREON™ (exenatide for extended-release injectable suspension).

23 Apr 2010

Actelion Pharmaceuticals launches Epoprostenol for Injection for treatment of primary pulmonary hypertension

Actelion Pharmaceuticals US, Inc. today announced the commercial availability of Epoprostenol for Injection, an improved formulation of epoprostenol that is stable at room temperature, for the treatment of primary pulmonary hypertension and pulmonary hypertension associated with scleroderma spectrum of disease in NYHA Class III and Class IV patients.

22 Apr 2010

New campaign highlights dangers of carrying excess weight around waist

Cancer Research UK has joined forces with the British Heart Foundation and Diabetes UK to launch a new campaign to raise awareness of the dangers of carrying excess weight around the waist.

22 Apr 2010

ISHLT announces new guidelines for heart transplant recipients

The International Society for Heart and Lung Transplantation (ISHLT) today announces new guidelines to standardize care for heart transplant patients worldwide. The guidelines demonstrate a united effort to decrease complications, improve outcomes and increase patient survival rates among heart transplant recipients. The guidelines will be presented during today's symposium The ISHLT Guidelines for Heart Transplant Recipients: Towards an International Consensus at the ISHLT 30th Annual Meeting and Scientific Sessions at the Hilton Chicago.

22 Apr 2010

Exercise News and Research

Latest Exercise News and Research

Exercise helps retain greater bone density: Researchers

Novartis exercises current right to purchase 55,223 unregistered shares of Alnylam's common stock

BioSante signs Option Agreement to obtain non-exclusive worldwide license for 2A/Furin technology

Covidien introduces PENNSAID to the U.S. market

Spring fever not an official medical condition

Overweight adolescent children tend to follow weight-control strategies of their parents: Study

NPAF urges Colorado Governor to exercise line item veto of $17.9M reduction in 2011 Medicaid program

Victoza produces greater reductions in A1C, FPG and body weight than Januvia: Study

Broadspire, Medcor partner to provide direct immediate post-injury treatment for employees

Arcadia Capital Advisors MD commences all-cash tender offer for CPEX Pharmaceuticals

Cipher Pharmaceuticals' first-quarter total revenue up 52%

More tips to protect lungs on elevated-ozone days

Micromedex clinical decision support and CareNotes content to be integrated within M2 HCIS

Medical Properties Trust closes underwritten public offering of common stock

Nile Therapeutics prices underwritten public offering of common stock

Physical exercise and computer use may help protect against mild cognitive impairment: Mayo Clinic

Amylin, Eli Lilly and Alkermes reply to FDA complete response letter for BYDUREON NDA

Actelion Pharmaceuticals launches Epoprostenol for Injection for treatment of primary pulmonary hypertension

New campaign highlights dangers of carrying excess weight around waist

ISHLT announces new guidelines for heart transplant recipients

How innovation in dried blood spot testing is transforming neurological disease monitoring

Unlocking live single-cell functional insights

Fluidics in Modern Healthcare & Medical Device Innovation

Exercise News and Research

Latest Exercise News and Research

How innovation in dried blood spot testing is transforming neurological disease monitoring

Unlocking live single-cell functional insights

Fluidics in Modern Healthcare & Medical Device Innovation

Newsletters you may be interested in